MedPath

Real-time Deflectable Guidewire in Neuro-interventions Study

Not Applicable
Recruiting
Conditions
Unruptured Cerebral Aneurysm
Interventions
Device: Standard of care guidewire (different models may be used)
Device: Deflectable guidewire
Registration Number
NCT05564325
Lead Sponsor
Artiria Medical
Brief Summary

The aim of the study is to assess the safe and successful use of the SmartGUIDE guidewire in neuro interventions and to compare to standard of care guidewires on the market.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
75
Inclusion Criteria
  • >18 years of age
  • Informed consent signed by patient
  • Confirmed cerebral unruptured aneurysm treatable via transcatheter approach
Exclusion Criteria
  • Pregnancy or lactation
  • Known disorder of vascular fragility with propensity to vascular injury (e.g., Ehlers-Danlos syndrome)
  • Known prior vascular stenosis or dissection or injury to vessels intended to be catheterized during study procedures
  • Acute phase myocardial infarction or uncontrolled cardiac arrhythmia
  • Uncontrolled serum electrolyte imbalance
  • Bleeding disorder which limits the use of antiplatelet and/or anticoagulant therapy
  • Known contraindication to intravascular contrast material that cannot be adequately controlled with pre-medication
  • Known hypersensitivity to Nickel
  • Subjects currently enrolled in another investigational device or drug study that clinically interferes with the current study endpoints

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Standard of care guidewireStandard of care guidewire (different models may be used)-
Deflectable guidewireDeflectable guidewire-
Primary Outcome Measures
NameTimeMethod
PerformanceDuring index procedure

Intra-procedural technical success defined as successful navigation of device to the vascular target vessel without need for shaping, removal or exchange.

Secondary Outcome Measures
NameTimeMethod
Procedural timesDuring index procedure

Procedural times (duration of tip reshaping, duration of access to target, duration of fluoroscopic exposition).

Safety - intra- and postproceduralDuring index procedure and up to 48 hours post procedure

Adverse events, measured by the occurrence of adverse events

Device DeficienciesDuring index procedure

Intraprocedural device deficiencies, measured by the occurrence of device deficiencies/malfunctions

UsabilityDuring index procedure

Usability data (pushability, trackability, navigatability, shape retention, support, and proximal access complexity) collected through questionnaire completed by the physician. Measured through a Likert scale from 1-5.

Trial Locations

Locations (2)

Centre Hospitalier Universitaire Vaudois (CHUV)

🇨🇭

Lausanne, Switzerland

Geneva University Hospital - HUG

🇨🇭

Geneva, Switzerland

© Copyright 2025. All Rights Reserved by MedPath